3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Interventions
Bevacizumab
32
Cetuximab
28
Fluorouracil
26
Leucovorin
24
Specimen Handling
23
Oxaliplatin
23
pembrolizumab
18
Biopsy
16
Magnetic Resonance Spectroscopy
14
Irinotecan
13
Nivolumab
9
atezolizumab
7
Folfox protocol
7
fludarabine
6
balstilimab
6
Pemetrexed
6
Panitumumab
6
Cyclophosphamide
6
Cisplatin
6
Carboplatin
6
Capecitabine
6
trifluridine tipiracil drug combination
5
encorafenib
5
Standard of Care
5
IFL protocol
5
HMPL-013
5
Gemcitabine
5
dehydroftorafur
4
Immunoglobulin G
4
Disulfides
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Indomethacin
×
30 days
×
Clear all
NCT01719926
2026-06-04
PIFA
UMC Utrecht
Phase 1
Completed
13 enrolled